Cargando…
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia
BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220944/ https://www.ncbi.nlm.nih.gov/pubmed/34218963 http://dx.doi.org/10.1016/j.vaccine.2021.06.048 |
_version_ | 1783711240445493248 |
---|---|
author | Trent, Mallory Seale, Holly Chughtai, Abrar Ahmad Salmon, Daniel MacIntyre, C. Raina |
author_facet | Trent, Mallory Seale, Holly Chughtai, Abrar Ahmad Salmon, Daniel MacIntyre, C. Raina |
author_sort | Trent, Mallory |
collection | PubMed |
description | BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-sectional survey of adults from Dynata’s research panel in July-September 2020. PARTICIPANTS, SETTING: Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. MAIN OUTCOMES AND MEASURES: Willingness to receive a COVID-19 vaccine; reason for vaccine intention. STATISTICAL METHODS: To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios. RESULTS: The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07–1.44 and PR = 1.38; 95% CI = 1.74–1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72–0.85 and PR = 0.85; 95% CI = 0.76–0.96). LIMITATIONS: Consumer panels can be subject to bias and may not be representative of the general population. CONCLUSIONS: Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine. |
format | Online Article Text |
id | pubmed-8220944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82209442021-06-23 Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia Trent, Mallory Seale, Holly Chughtai, Abrar Ahmad Salmon, Daniel MacIntyre, C. Raina Vaccine Article BACKGROUND: There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. OBJECTIVE: To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. DESIGN: Online, cross-sectional survey of adults from Dynata’s research panel in July-September 2020. PARTICIPANTS, SETTING: Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. MAIN OUTCOMES AND MEASURES: Willingness to receive a COVID-19 vaccine; reason for vaccine intention. STATISTICAL METHODS: To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios. RESULTS: The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07–1.44 and PR = 1.38; 95% CI = 1.74–1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72–0.85 and PR = 0.85; 95% CI = 0.76–0.96). LIMITATIONS: Consumer panels can be subject to bias and may not be representative of the general population. CONCLUSIONS: Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine. The Authors. Published by Elsevier Ltd. 2022-04-14 2021-06-23 /pmc/articles/PMC8220944/ /pubmed/34218963 http://dx.doi.org/10.1016/j.vaccine.2021.06.048 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Trent, Mallory Seale, Holly Chughtai, Abrar Ahmad Salmon, Daniel MacIntyre, C. Raina Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia |
title | Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia |
title_full | Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia |
title_fullStr | Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia |
title_full_unstemmed | Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia |
title_short | Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia |
title_sort | trust in government, intention to vaccinate and covid-19 vaccine hesitancy: a comparative survey of five large cities in the united states, united kingdom, and australia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220944/ https://www.ncbi.nlm.nih.gov/pubmed/34218963 http://dx.doi.org/10.1016/j.vaccine.2021.06.048 |
work_keys_str_mv | AT trentmallory trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia AT sealeholly trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia AT chughtaiabrarahmad trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia AT salmondaniel trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia AT macintyrecraina trustingovernmentintentiontovaccinateandcovid19vaccinehesitancyacomparativesurveyoffivelargecitiesintheunitedstatesunitedkingdomandaustralia |